Seven Indiana cities are recognized for their national life science strengths, according to Biotechnology Industry Organization (BIO) and TEConomy Partners’ biennial survey of the U.S. life sciences industry released today. Bloomingto
INDIANAPOLIS, June 9, 2020 /PRNewswire/ -- Seven Indiana cities are recognized for their national life science strengths, according to Biotechnology Industry Organization (BIO) and TEConomy Partners’ biennial survey of the U.S. life sciences industry released today. Bloomington, Evansville, Indianapolis, Lafayette, Michigan City, South Bend and Terre Haute are identified in the report as having significant life sciences activity. Lafayette is one of only seven cities in the U.S. to have employment specializations in four of the five industry subsectors. Bloomington and Indianapolis have employment specializations in three of the five industry subsectors (two of only 23 cities in the U.S. with that distinction). The report, The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities, measures growth in the bioscience sector (Agricultural Feedstock and Chemicals, Drugs and Pharmaceuticals, Medical Devices and Research, Testing and Medical Laboratories and Bioscience-related Distribution) from 2016 to 2018 for the entire country and each of the fifty states. Highlighted as a national leader in life sciences sector employment, with sizeable employment and industry concentration in the areas of agriculture feedstock and chemicals, drugs and pharmaceuticals, and medical devices and equipment, Indiana continued its top 10 employment ranking in the life sciences. The state is also one of only nine states with employment specializations in three of five bioscience sectors. In addition, Indiana is ranked eighth for National Institutes of Health funding growth, with an increase of 44 percent over the years 2016 to 2019. “Indiana’s life sciences are unique in their product and geographic diversity. Medical devices, biotech, pharmaceuticals, agricultural products, and research testing are found in all four corners of the state, and many areas are growing,” said Patty Martin, president and CEO of BioCrossroads, said. “Whether it is in our major metro areas or smaller cities, important, innovative and life-saving work is driving the health of Hoosiers as well as the health of our state economy.”
Indiana is home to the global headquarters of Anthem, Inc., Cook Medical, Eli Lilly and Company, and Zimmer Biomet and the North American headquarters of Roche Diagnostics; Beckman Coulter, Boston Scientific, Catalent Biologics, Corteva Agriscience, Covance, DePuy Orthopaedics, Express Scripts, Medtronic, and Reckitt Benckiser all host major operations in the state. According to the report, 1.87 million people work in the U.S. bioscience industry, which has seen employment growth of 7.2 percent since 2016, twice the rate of other private sector industries. In addition, the sector contributes more than $2.6 trillion to the U.S. economy. The full report is available at https://www.bio.org. About BioCrossroads *All cities listed are inclusive of their metropolitan statistical areas. View original content to download multimedia:http://www.prnewswire.com/news-releases/indianas-life-sciences-industry-ranks-among-the-top-10-in-national-report-301073108.html SOURCE BioCrossroads |